Torrent Pharmaceuticals Ltd - Company Profile
Powered by 
All the sales intelligence you need on Torrent Pharmaceuticals Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Torrent Pharmaceuticals Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Torrent Pharmaceuticals Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Torrent Pharmaceuticals Ltd (Torrent) is a pharmaceutical company. It specializes in the manufacturing, marketing, and distribution of branded generics and generic pharmaceutical products. Its primary focus is on cardiovascular, urology, central nervous system, gastrointestinal, diabetology, anti-infective, and pain management. The company also offers medicines for the treatment of nephrology, cancer, gynecology and pediatric-related conditions. It offers contract manufacturing services for the formulation of active pharmaceutical ingredients (APIs). Torrent operates its manufacturing units in India. The company has operations in the US, the UK, Germany, Russia, Brazil, Mexico, the Philippines and other major markets. Torrent is headquartered in Ahmedabad, Gujarat, India.
Headquarters
India
Address
Avirat, Thaltej Shilaj Road, Ahmedabad, Gujarat, 380059
Website
www.torrentpharma.com
Telephone
91 79 26599000
No of Employees
17,320
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
TORNTPHARM (NSE)
Revenue (2025)
$1.6B
21.4%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
13.2%
(2025 vs 2024)
Market Cap*
$17.1B
Net Profit Margin (2025)
XYZ
-6.8%
(2025 vs 2024)
* As of and is in US$
Torrent Pharmaceuticals Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Therapy Areas: | Shelcal 500 |
| Cardiovascular (CV) | Nikoran 5 |
| Central Nervous System (CNS) | Nexpro RD 40 |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Regulatory Approval | In October, the company secured approval from the Subject Expert Committee to develop and market a Fixed-Dose Combination of Alogliptin benzoate (17 mg) and Metformin Hydrochloride (850 mg) film-coated tablets. |
| 2025 | Contracts/Agreements | In September, the company signed a Share Subscription and Shareholders' Agreement to acquire a 26% equity stake in Torrent Urja 27 Private Limited. |
| 2025 | New Products/Services | In August, the company launched Shelcal Total, an adult nutrition supplement powder. |
Competitor Comparison
| Key Parameters | Torrent Pharmaceuticals Ltd | Sun Pharmaceutical Industries Ltd | Intas Pharmaceuticals Ltd | Mankind Pharma Ltd | Divi's Laboratories Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Ahmedabad | Mumbai | Ahmedabad | New Delhi | Hyderabad |
| State/Province | Gujarat | Maharashtra | Gujarat | Delhi | Telangana |
| No. of Employees | 17,320 | 43,000 | - | 27,000 | 18,300 |
| Entity Type | Public | Public | Private | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Samir Uttamlal Mehta | Chairman | Executive Board | 2014 | 62 |
| Sudhir Menon | Director - Finance; Chief Financial Officer | Senior Management | 2018 | - |
| Geena Malhotra | Chief Technology Officer | Senior Management | 2026 | - |
| Aman Mehta | Managing Director; Director; Director - JB Chemicals and Pharmaceuticals Ltd | Executive Board | 2025 | - |
| Hasmukh Patel | Chief Operating Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer